Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study

Patient

Sex

Age at diagnosis of LCH (years)

Age at diagnosis of CNS involvement (years)

Localisation of CNS mass lesion

Other sites of LCH involvement

Symptoms

1

F

10

12

hp

Bone, skin

Diabetes insipidus

2

F

50

53

p (brainstem)

mastoid

Cerebellar ataxia

3

F

26

28

hp

None

Cognitive impairment, bulimia, diabetes insipidus

4

M

9

9

hp

None

Diabetes insipidus

5

M

21

34

p (multifocal: frontal and brainstem)

Bone, lung

Cerebellar ataxia, cranial nerve palsies, hemiparesis, diabetes insipidus

6

F

2

3

hp

Skin

Diabetes insipidus

7

M

41

44

hp

Lung

Cognitive impairment, diabetes insipidus

8

F

3

3

hp

Skin, bone, thyroid

Diabetes insipidus

9

F

7

7

hp

Skin, lung

Diabetes insipidus

10

F

1

10

hp

Skin, bone,

Visual field defect

11

F

4

4

hp and m

Bone

Diabetes insipidus

12

M

26

30

hp and p (brainstem)

Skin, lung, parotid, liver

Hemiparesis, headaches

13

M

35

35

hp

Bone

Diabetes insipidus

14

F

15

16

hp

None

Headaches

15

F

2

12

p (multifocal: temporal, frontal, parietal lobes)

Bone, skin

Diabetes insipidus

16

M

28

28

hp

Bone

Cognitive impairment, diabetes insipidus

17

F

15

15

hp

None

Visual field defect, diabetes insipidus

18

M

1

5, 5

hp

Bone, skin

Diabetes insipidus

19

F

12

12, 1

hp

None

Diabetes insipidus

20

M

11

11

p (cerebellum)

None

Cerebellar ataxia

  1. CNS = central nervous system, F = female, hp = hypothalamo-pituitary region involvement, LCH = Langerhans cell histiocytosis, M = male, p = parenchymal involvement, m = meningeal involvement.